• 

  June 25, 2025

  Biofabricated Organ Support: miroliverELAP’s First Human Treatment for Acute Liver Failure

  R.D. Solorzano

• 

  June 4, 2025

  Vivodyne Raises $40M to Scale AI and Robotics-Driven Human Tissue Platform for Drug Discovery

  William Ernst

• 

  June 4, 2025

  Vital3D Targets Pet Care Market as Strategic Entry Point to Bioprinted Human Organs

  William Ernst

• 

  May 8, 2025

  OrganOx Secures $160M in Private Financing to Accelerate Organ Perfusion Technology Expansion

  R.D. Solorzano

• 

  May 6, 2025

  Collagen-Based 3D Bioprinting Offers Fully Perfusable Gel Based Organ-On-Chips

  R.D. Solorzano

• 

  May 6, 2025

  Quris Technologies Demonstrates Liver-Driven Brain Toxicity in New Multi-Organ Model

  R.D. Solorzano

• 

  May 6, 2025

  VivoSim Labs Introduces NAMkind Platform for Human-Based Drug Testing Models

  R.D. Solorzano

• 

  April 27, 2025

  Cellino and Karis Bio Partner to Advance Personalized iPSC Therapies for Peripheral Artery Disease

  R.D. Solorzano

• 

  April 27, 2025

  Vivodyne CEO Discusses FDA’s Move Away from Animal Testing and the Future of Humanized Drug Development

  R.D. Solorzano

• 

  April 27, 2025

  Organovo Rebrands as VivoSim Labs to Advance 3D Bioprinting Technology

  R.D. Solorzano